Expression and Clinical Significance of BCL2 Interacting Protein 3 Like in Multiple Myeloma

Expression and Clinical Significance of BCL2 Interacting Protein 3 Like in Multiple Myeloma

Multiple myeloma (MM) is one of the main blood disorders threatening human health today. This study aimed to examine the expression of BCL-2/adenovirus E1B 19 kDa-interacting protein 3-like (BNIP3L) in patients with MM and explore its mechanisms in silico. Bone marrow samples (n = 36 from patients w...

Full description

Bibliographic Details
Main Authors:	Ruolin Li, Gang Chen, Yiwu Dang, Rongquan He, Angui Liu, Jie Ma, Zhian Ling
Format:	Article
Language:	English
Published:	SAGE Publishing 2021-06-01
Series:	Technology in Cancer Research & Treatment
Online Access:	https://doi.org/10.1177/15330338211024551

Similar Items

P848: EXPRESSION PROFILE OF BCL-2 FAMILY PROTEINS IN MULTIPLE MYELOMA.
by: Cristina De Ramón Sánchez, et al.
Published: (2023-08-01)

BCL2 Family Inhibitors in the Biology and Treatment of Multiple Myeloma
by: Gupta VA, et al.
Published: (2021-03-01)

BCL-B (BCL2L10) is overexpressed in patients suffering from multiple myeloma (MM) and drives an MM-like disease in transgenic mice
by: Fenouille, Nina
Published: (2017)

Role and Regulation of Pro-survival BCL-2 Proteins in Multiple Myeloma
by: Anne Slomp, et al.
Published: (2018-11-01)

Expression and clinical significance of LncRNA CBR3-AS1 in multiple myeloma
by: ZHANG Yongmei, ZHANG Zhiming, ZHOU Jie, PAN Zhilan, FENG Liqian, YANG Yan
Published: (2023-06-01)

Thymoquinone decreases F-actin polymerization and the proliferation of human multiple myeloma cells by suppressing STAT3 phosphorylation and Bcl2/Bcl-<sub>XL </sub>expression
by: Badr Gamal, et al.
Published: (2011-12-01)

Mechanisms of action of the BCL-2 inhibitor venetoclax in multiple myeloma: a literature review
by: Qiang Cao, et al.
Published: (2023-11-01)

The Latest Overview of circRNA in the Progression, Diagnosis, Prognosis, Treatment, and Drug Resistance of Hepatocellular Carcinoma
by: Dandan Xiong, et al.
Published: (2021-02-01)

Prognostic significance of CD56 expression in patients with multiple myeloma: a meta-analysis
by: Lijuan Zhang, et al.
Published: (2022-12-01)

Characterization of the Toll-like receptor expression profile in human multiple myeloma cells.
by: Jahangir Abdi, et al.
Published: (2013-01-01)

Clinical-Laboratory Significance of Myelofibrosis in Patients with Multiple Myeloma
by: Yuliya A. D'yachkova, et al.
Published: (2014-06-01)

Cytogenetic profiles and their clinical significance in relapsed multiple myeloma
by: Lin, Qian Yu
Published: (2023)

The significance of prognostic profiling in the treatment of patients with multiple myeloma
by: Mitrović Marko, et al.
Published: (2020-01-01)

Frequency and prognostic significance of hypercalcemia in patients with multiple myeloma
by: Kanar J Karim, et al.
Published: (2020-01-01)

Updates in the Use of BCL-2-Family Small Molecule Inhibitors for the Treatment of Relapsed/Refractory Multiple Myeloma
by: Ricardo D. Parrondo, et al.
Published: (2022-07-01)

Clinical significance of granule‐containing myeloma cells in patients with newly diagnosed multiple myeloma
by: Kazuhito Suzuki, et al.
Published: (2016-11-01)

NSO myeloma cell death: Influence of bcl-2 overexpression.
by: Murray, K, et al.
Published: (1996)

Role of flow cytometry in multiple myeloma and the prognostic significance of CD87 (uPAR) expression
by: Murat Albayrak, et al.
Published: (2010-09-01)

Role of flow cytometry in multiple myeloma and the prognostic significance of CD87 (uPAR) expression
by: Murat Albayrak, et al.
Published: (2010-10-01)

Carbamazepine and Multiple Myeloma: Possible Interaction
by: Meral Günaldı, et al.
Published: (2013-03-01)

Significance of Bcl-2 and Bcl-6 immunostaining in B-Non Hodgkin's lymphoma
by: Hanan Mohamed Mahmoud, et al.
Published: (2011-11-01)

Imaging of Monoclonal Gammapathy of Undetermined Significance and Smoldering Multiple Myeloma
by: Bastien Jamet, et al.
Published: (2020-02-01)

Clinical significance of cyclooxygenase-2 (COX-2) in multiple myeloma
by: M Tinguely, et al.
Published: (2006-07-01)

A novel microrna signature with clinical significance in multiple myeloma
by: A. Papanota, et al.
Published: (2020-10-01)

Expression of PRAME gene in multiple myeloma
by: I В Abramenko, et al.
Published: (2004-07-01)

Flower-Like Plasma Cell Nuclei in Multiple Myeloma
by: Abibatou Sall, et al.
Published: (2021-06-01)

Expression Pattern and Biological Significance of the lncRNA ST3GAL6-AS1 in Multiple Myeloma
by: Domenica Ronchetti, et al.
Published: (2020-03-01)

Dinaciclib synergizes with BH3 mimetics targeting BCL‐2 and BCL‐XL in multiple myeloma cell lines partially dependent on MCL‐1 and in plasma cells from patients
by: Manuel Beltrán‐Visiedo, et al.
Published: (2023-12-01)

A personalized molecular approach in multiple myeloma: the possible use of RAF/RAS/MEK/ERK and BCL-2 inhibitors
by: Vincenzo Raimondi, et al.
Published: (2022-08-01)

Expression of PD-L1 and Its Clinical Significance in MYC/BCL2 Double-expression Large B Cell Lymphoma
by: WANG Ping, et al.
Published: (2020-01-01)

Prognostic significance of β2-microglobulin decline index in multiple myeloma
by: Tianyu Zhang, et al.
Published: (2024-03-01)

The Significance of mRNA in the Biology of Multiple Myeloma and Its Clinical Implications
by: Anna Puła, et al.
Published: (2021-11-01)

Clinical Significance of TP53 Abnormalities in Newly Diagnosed Multiple Myeloma
by: Fang Ye, et al.
Published: (2021-12-01)

Minimal residual disease detection in multiple myeloma: methods and prognostic significance
by: Evangelos Terpos
Published: (2020-10-01)

Significance of pathohistological findings and the expression of Bcl-2 in diagnosis and treatment of oral planocellular carcinoma
by: Lončarević Slobodan, et al.
Published: (2012-01-01)

Clinical significance of BCL2L10 expression and promoter methylation in myelodysplastic syndrome
by: JI Yueru, et al.
Published: (2020-09-01)

Myeloma cells isolated from patients with multiple myeloma express osteoprotegerin ligand.
by: Shipman, C, et al.
Published: (2000)

Ubiquitination and Ubiquitin-Like Modifications in Multiple Myeloma: Biology and Therapy
by: Matthias Wirth, et al.
Published: (2020-12-01)

Identification and Characterization of Multiple Myeloma Stem Cell-Like Cells
by: Wancheng Guo, et al.
Published: (2021-07-01)

Auer Rod-like Inclusions in a Patient with Multiple Myeloma
by: Nouama Bouanani, et al.
Published: (2022-11-01)